Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
4(27%)
Results Posted
100%(4 trials)
Terminated
1(7%)

Phase Distribution

Ph phase_3
4
27%
Ph phase_2
1
7%
Ph not_applicable
6
40%
Ph phase_4
3
20%

Phase Distribution

0

Early Stage

1

Mid Stage

7

Late Stage

Phase Distribution14 total trials
Phase 2Efficacy & side effects
1(7.1%)
Phase 3Large-scale testing
4(28.6%)
Phase 4Post-market surveillance
3(21.4%)
N/ANon-phased studies
6(42.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

4

trials recruiting

Total Trials

15

all time

Status Distribution
Active(6)
Completed(4)
Terminated(1)
Other(4)

Detailed Status

Completed4
unknown4
Recruiting3
Not yet recruiting2
Active, not recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
15
Active
4
Success Rate
80.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (7.1%)
Phase 34 (28.6%)
Phase 43 (21.4%)
N/A6 (42.9%)

Trials by Status

completed427%
recruiting320%
not_yet_recruiting213%
unknown427%
active_not_recruiting17%
terminated17%

Recent Activity

Clinical Trials (15)

Showing 15 of 15 trials
NCT07754682Phase 3

Immunoglobulin Replacement Therapy (IgRT) Versus Antibiotic Prophylaxis (PA) in Patients Treated by CD19-targeted Chimeric Antigen Receptor (CAR)T Cells for a B Cell Acute Lymphoblastic Leukemia or a B Cell Lymphoma

Not Yet Recruiting
NCT07107477Phase 3

TAILORED Therapeutic Regime in Patients With Preterm Premature Rupture Of Membranes to Prolong Pregnancy, Improve Maternal and Neonatal Outcomes, and Reduce Antibiotic Burden

Recruiting
NCT06801405

Antibiotic Prophylaxis in Percutaneous Nephrostomy Placements and Replacements for Malignant Urinary Tract Obstruction

Completed
NCT04815876Not Applicable

PReclude Infection EVEnts With No Prophylaxis Transperineal Biopsy 2

Completed
NCT07209150Phase 3

Randomized Controlled Trial of Different Antibiotic Duration Prior to Prostate Enucleation Surgery

Not Yet Recruiting
NCT07077122Not Applicable

Evaluation of the Systemic Burden of Non-surgical Periodontal Therapy: A Randomized Clinical Trial on Five Different Treatment Protocols

Recruiting
NCT01407263Phase 3

Trial of Modifications to Radical Prostatectomy

Active Not Recruiting
NCT04999592Phase 2

Ceftriaxone to PRevent pneumOnia and inflammatTion aftEr Cardiac arresT (PROTECT)

Terminated
NCT04843566Not Applicable

PReclude Infection EVEnts With No Prophylaxis Transperineal Biopsy

Completed
NCT06810687Not Applicable

Is Methenamine Prophylaxis for Urinary Tract Infection After Midurethral Sling as Effective as Antibiotic Prophylaxis?

Recruiting
NCT04856319Not Applicable

The Effect of Pre-operative Single Dose Antibiotic Prophylaxis on the Post-operative Implant Success

Unknown
NCT05438082Phase 4

Antibiotic Prophylaxis to Prevent Post-procedure UTI After VCUG

Unknown
NCT02357758Phase 4

Effects of Antibiotic Prophylaxis on Recurrent UTI in Children

Completed
NCT01945450Not Applicable

Prophylactic Antibiotics for Manual Removal of Retained Placenta in Vaginal Birth: a Randomized Controlled Trial

Unknown
NCT01612052Phase 4

Vascular Surgical Antibiotic Prophylaxis Study (VSAPS 2)

Unknown

All 15 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
15